Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today ...

Nothing went according to plan for David Reinbacher this season, he didn't plan to lose the campaign to a serious knee injury ...

自2022年3月诺华公司推出 ...

2025年2月14日， Sera Prognostics（SERA）披露4笔公司内部人交易情况。高管Harrison Robert Gardner于2025年2月13日卖出7297股。 Sera Prognostics, ...

Lindgardt Zhenya, the Chief Executive Officer of Sera Prognostics , Inc. (NASDAQ:SERA), recently sold 14,075 shares of the company's Class A common stock. The shares were sold at a weighted average ...

Boniface John J., the Chief Scientific Officer of Sera Prognostics , Inc. (NASDAQ:SERA), recently sold 5,915 shares of the company's Class A Common Stock. The shares were sold at a weighted average ...

盐湖城讯— Sera Prognostics , Inc. (NASDAQ: SERA )首席执行官Lindgardt Zhenya近期出售了14,075股公司A类普通股。根据 InvestingPro 数据显示，这些股票以加权平均价$4.58售出，交易总额达$64,463。此次交易发生之际，该股票接近其52周低点$3.84，技术指标显示超卖状态。

盐湖城讯— Sera Prognostics , Inc. (NASDAQ: SERA )的首席科学官Boniface John J.近期出售了5,915股公司A类普通股。这些股票以加权平均价$4.58出售，总计获得$27,090。此次交易是在$4.14至$5.09价格区间内完成的大宗交易的一部分。此次出售发生之际，SERA股价接近其52周低点$3.84，今年迄今股价下跌超过47%。

The firm plans to use the proceeds to support commercial expansion in the US and EU, and for research, potential regulatory submissions, and general corporate purposes.

Sera Prognostics (SERA) announced the pricing of its underwritten public offering of 1.25M shares of its Class A common stock at a public ...

Sera intends to use the net proceeds from the offering to expand its commercial infrastructure and capabilities in the United States, accelerate preparations for expansion in the European Union, fund ...

Sera Prognostics (SERA) announced that it has commenced a proposed underwritten public offering of its Class A common stock and, in lieu of ...